A multicenter, retrospective study evaluating effectiveness and safety of lusutrombopag for Chronic Liver Disease and severe thrombocytopenia
Latest Information Update: 07 Jun 2021
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2021 New trial record